Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
about
Co-opting biology to deliver drugsCarrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapyA Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In VivoNew aspects of gene-silencing for the treatment of cardiovascular diseasesSite-specific antibody-polymer conjugates for siRNA delivery.Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene.Bioresponsive polymers for the delivery of therapeutic nucleic acids.Cholesterol as a potential target for castration-resistant prostate cancer.Recent advances in ligand targeted therapy.Oligonucleotide conjugates for therapeutic applications.Guiding principles in the design of ligand-targeted nanomedicines.Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles.FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing.PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.
P2860
Q34424045-2672A8DD-DA35-4360-ACE2-52992CE2ADA2Q35823611-661EA070-5157-49CE-AE10-DFD3696C379AQ37194020-34856DE7-DF7B-4556-A3D4-5C3BD820191BQ37258262-F38EDE76-7D3D-4937-8CBF-344020DEE2CFQ37277425-9DD0B479-DAE2-4A0F-8960-FEC01EE70E66Q37638814-3E920FD2-92BA-40BF-837A-759C49C9501EQ37718210-7F25F179-4507-473D-AB87-71084604C96BQ37763677-DC627663-8648-425C-AC94-0AABBDA7709AQ37777663-28EE539A-11CB-4FF6-BC00-B2F1D96CB904Q37937611-EF18786E-4409-4BA1-AF6E-6A1DE413523AQ38123854-7637BE9E-7A4E-4C46-A223-D204DE09DEF9Q38189490-51A7709E-8689-4A94-8016-073A0BDD3BDBQ39257622-7303FF9C-8CD3-4AD0-B058-577E8CB84405Q41557167-EFB5B9B4-B099-4EF0-9413-9001C1E2E723Q42155861-3A90D0A9-BD58-4D49-B243-45C1E02363DAQ49920174-929C1B27-4918-40F1-B7BF-2A2BF0A83C82
P2860
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@ast
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@en
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@nl
type
label
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@ast
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@en
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@nl
prefLabel
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@ast
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@en
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@nl
P2093
P1476
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
@en
P2093
Christopher P Leamon
Michael J Hansen
Mini Thomas
Paul Kleindl
Sumith A Kularatne
P356
10.1111/J.1749-6632.2009.04977.X
P407
P577
2009-09-01T00:00:00Z